2027 NCODA Global Oncology & Haematology Congress
March 10, 2027 | 9:00 AM EST
- Syracuse University – Martin J. Whitman School of Management
- Celcuity Inc.
- California
About Eldon
With over 30 years in biopharma, Eldon Mayer has held roles leading commercial opera:ons at mul:ple companies including Questcor, Rigel, and Eiger Biopharmaceu:cals. At Celcuity, he is leading the effort to prepare for the poten:al launch of a new treatment for advanced breast cancer. Eldon holds a BS from Fairleigh Dickinson University and an MBA from Syracuse University.
Send your feedback
Please do not include any personal information or details.
"*" indicates required fields
Was this page
helpful?
Send your feedback
Please do not include any personal information or details.
"*" indicates required fields